Inovio Pharmaceuticals
INO
INO
214 hedge funds and large institutions have $1.52B invested in Inovio Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 92 funds opening new positions, 73 increasing their positions, 31 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
17% more call options, than puts
Call options by funds: $269M | Put options by funds: $230M
0.47% more ownership
Funds ownership: 2.51% → 2.98% (+0.47%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
214
Holding in Top 10
–
Calls
$269M
Puts
$230M
Top Buyers
| 1 | +$144M | |
| 2 | +$139M | |
| 3 | +$108M | |
| 4 |
Coatue Management
New York
|
+$74.1M |
| 5 |
Jane Street
New York
|
+$22.9M |
Top Sellers
| 1 | -$57.2M | |
| 2 | -$50.6M | |
| 3 | -$42.5M | |
| 4 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$40M |
| 5 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
-$23.4M |